2013
DOI: 10.1590/1516-3180.2013.1314467 View full text |Buy / Rent full text
|
|

Abstract: CONTEXT AND OBJECTIVES: Sickle cell disease (SCD) is the most common genetic disorder among people of African descent, affecting approximately 3,500 newborns each year in Brazil. Hydroxyurea (HU) is the only effective drug to treating patients with SCD, thereby reducing morbidity and mortality. The objective was to analyze the effects of HU on SCD patients at our institution. DESIGN AND SETTING:Retrospective study conducted at a sickle cell centre in Ribeirão Preto, São Paulo, Brazil. METHODS:We analyzed clini… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
5
31
2
5

Publication Types

Select...

Relationship

0
0

Authors

Journals